Mirum Pharmaceuticals, Inc. (MIRM)
USD 41.5
(-4.0%)
USD 41.5
(-4.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 306.42 Million USD | 24277.17% |
| 2022 | 1.25 Million USD | -33.95% |
| 2021 | 1.9 Million USD | -27.56% |
| 2020 | 2.62 Million USD | -19.19% |
| 2019 | 3.25 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 307.24 Million USD | 0.13% |
| 2024 Q1 | 307.16 Million USD | 0.14% |
| 2023 Q4 | 306.42 Million USD | 0.13% |
| 2023 Q3 | 306.02 Million USD | -0.24% |
| 2023 FY | 306.42 Million USD | 24277.17% |
| 2023 Q1 | 1.05 Million USD | -16.07% |
| 2023 Q2 | 306.76 Million USD | 28977.25% |
| 2022 Q2 | 1.51 Million USD | -11.44% |
| 2022 Q1 | 1.71 Million USD | -9.98% |
| 2022 FY | 1.25 Million USD | -33.95% |
| 2022 Q4 | 1.25 Million USD | -4.12% |
| 2022 Q3 | 1.31 Million USD | -13.58% |
| 2021 Q1 | 2.45 Million USD | -6.66% |
| 2021 FY | 1.9 Million USD | -27.56% |
| 2021 Q4 | 1.9 Million USD | -8.86% |
| 2021 Q3 | 2.08 Million USD | -8.06% |
| 2021 Q2 | 2.27 Million USD | -7.38% |
| 2020 Q1 | 3.1 Million USD | -4.55% |
| 2020 Q4 | 2.62 Million USD | -5.77% |
| 2020 FY | 2.62 Million USD | -19.19% |
| 2020 Q3 | 2.78 Million USD | -5.4% |
| 2020 Q2 | 2.94 Million USD | -5.03% |
| 2019 Q3 | 1.12 Million USD | -9.35% |
| 2019 Q1 | 1.19 Million USD | 0.0% |
| 2019 FY | 3.25 Million USD | 0.0% |
| 2019 Q4 | 3.25 Million USD | 189.23% |
| 2019 Q2 | 1.24 Million USD | 4.2% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -330.234% |
| Alkermes plc | 287.73 Million USD | -6.496% |
| Agenus Inc. | 137.32 Million USD | -123.137% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 86.922% |
| Aptorum Group Limited | 3.05 Million USD | -9918.669% |
| Ardelyx, Inc. | 51.54 Million USD | -494.45% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -192.923% |
| Bicycle Therapeutics plc | 40.08 Million USD | -664.523% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -204.599% |
| ChromaDex Corporation | 2.57 Million USD | -11799.845% |
| Chimerix, Inc. | 125 Thousand USD | -245036.8% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -9361.436% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1082.727% |
| CRISPR Therapeutics AG | 223 Million USD | -37.404% |
| Precision BioSciences, Inc. | 7.72 Million USD | -3867.642% |
| Dyadic International, Inc. | 88.87 Thousand USD | -344696.894% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -1392722.727% |
| Fortress Biotech, Inc. | 60.85 Million USD | -403.518% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -498177.937% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -7961.589% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -339899.334% |
| Incyte Corporation | 29.16 Million USD | -950.754% |
| IO Biotech, Inc. | 1.83 Million USD | -16562.371% |
| Jaguar Health, Inc. | 30.99 Million USD | -888.678% |
| Novavax, Inc. | 168.01 Million USD | -82.376% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1230.819% |
| Opthea Limited | 200.53 Million USD | -52.801% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -5224.431% |
| ContextLogic Inc. | 6 Million USD | -5007.017% |
| MiMedx Group, Inc. | 48.09 Million USD | -537.063% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -1424.558% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -800142.877% |
| NextCure, Inc. | 5.94 Million USD | -5050.798% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -211224.828% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -1285.831% |
| PDS Biotechnology Corporation | 19.5 Million USD | -1470.892% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -165.346% |
| Pharming Group N.V. | 166.1 Million USD | -84.474% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -4831.933% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -814.28% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -25308.043% |
| Acelyrin, Inc. | 1.19 Million USD | -25563.4% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -66513.261% |
| Summit Therapeutics Inc. | 103.29 Million USD | -196.661% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -8030.034% |
| Senti Biosciences, Inc. | 33.53 Million USD | -813.653% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -6319.883% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -786.737% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -407.984% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -19417.261% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1106.192% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -193.681% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -41760.792% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -2638.102% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -121.556% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -2180.088% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -1942.807% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -60.487% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -481.908% |
| Fortress Biotech, Inc. | 60.85 Million USD | -403.518% |
| Precigen, Inc. | 5.89 Million USD | -5097.981% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -629.782% |
| AlloVir, Inc. | 16.64 Million USD | -1740.587% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -365.99% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -214.73% |
| ImmuCell Corporation | 10.54 Million USD | -2807.083% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -27137.422% |
| Onconetix, Inc. | 118.85 Thousand USD | -257706.44% |
| PureTech Health plc | 18.25 Million USD | -1579.019% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -309416.162% |
| Elevation Oncology, Inc. | 30.13 Million USD | -916.76% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -1080.176% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -614.701% |
| Innoviva, Inc. | 446.23 Million USD | 31.332% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -36685.234% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -458312.124% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -48.052% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -330.391% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -9511.7% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -29420.328% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -1272.485% |
| Aptose Biosciences Inc. | 621 Thousand USD | -49243.156% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -30210.683% |
| Century Therapeutics, Inc. | 46.65 Million USD | -556.738% |
| Kura Oncology, Inc. | 9.33 Million USD | -3183.551% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -1047.644% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -221944.203% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -3165.008% |
| Autolus Therapeutics plc | 47.91 Million USD | -539.523% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -6145.842% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -4424.155% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -134.518% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -3680.642% |
| IGM Biosciences, Inc. | 34.67 Million USD | -783.771% |
| INmune Bio, Inc. | 397 Thousand USD | -77084.131% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -76.354% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -7458.001% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -208422.004% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -515.649% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -461.519% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -570.608% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 35.268% |
| Verastem, Inc. | 40.08 Million USD | -664.409% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -6860.95% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -2947.752% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -4570.34% |
| Histogen Inc. | 4.38 Million USD | -6889.53% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -34641.61% |
| Organovo Holdings, Inc. | 888 Thousand USD | -34406.869% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -921.403% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -7206.175% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -1521.704% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -304.783% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -329016.902% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1082.773% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -114664.419% |
| Amarin Corporation plc | 8.73 Million USD | -3407.165% |
| Mesoblast Limited | 100.48 Million USD | -204.948% |
| Turnstone Biologics Corp. | 1.18 Million USD | -25671.32% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -291.197% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -281020.183% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -273.643% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -61.322% |
| Better Therapeutics, Inc. | 10.34 Million USD | -2861.162% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1225.064% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -229.368% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -23616.796% |
| Gritstone bio, Inc. | 40.14 Million USD | -663.305% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -16792.007% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -99.502% |
| Insmed Incorporated | 1.19 Billion USD | 74.323% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -4725.528% |
| OmniAb, Inc. | 22.07 Million USD | -1288.091% |
| Alector, Inc. | 30.45 Million USD | -906.11% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -201.762% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -3707.891% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 28.171% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1716.366% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -438.582% |
| Immunic, Inc. | 639 Thousand USD | -47853.208% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -927.603% |
| Veracyte, Inc. | 7.52 Million USD | -3972.04% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 52.483% |
| FibroGen, Inc. | 89.69 Million USD | -241.618% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -6965.276% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -234054.039% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 94.001% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -828064.865% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -15375.808% |
| TG Therapeutics, Inc. | 100.11 Million USD | -206.06% |
| Galecto, Inc. | 66 Thousand USD | -464174.242% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -225209.559% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 81.229% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -4994.281% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -5577.617% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -16792.007% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -1328.736% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -738.246% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -59169.052% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -577.383% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -902.227% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -583.945% |
| Vaxxinity, Inc. | 13.26 Million USD | -2210.519% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 62.229% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -68137.157% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -3386.415% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 88.663% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -96868.671% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -6773.508% |
| Ainos, Inc. | 5.92 Million USD | -5074.67% |
| Pluri Inc. | 29.05 Million USD | -954.697% |
| Prothena Corporation plc | 10.72 Million USD | -2758.138% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -1443.605% |
| Celularity Inc. | 26.17 Million USD | -1070.573% |
| Rallybio Corporation | 173 Thousand USD | -177021.965% |
| Cue Biopharma, Inc. | 4.2 Million USD | -7192.266% |
| MeiraGTx Holdings plc | 72.11 Million USD | -324.882% |
| Omeros Corporation | 329.7 Million USD | 7.062% |
| Humacyte, Inc. | 38.6 Million USD | -693.837% |
| Immunocore Holdings plc | 82.64 Million USD | -270.772% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -18896.962% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -8466.424% |
| Blueprint Medicines Corporation | 610.96 Million USD | 49.846% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -20916.529% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -221.908% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -529.408% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -237.093% |
| Pulmatrix, Inc. | 8.32 Million USD | -3579.849% |
| Elicio Therapeutics, Inc. | 6 Million USD | -5001.065% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -2267.099% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -216.724% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -65234.968% |
| Cytokinetics, Incorporated | 607.37 Million USD | 49.55% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -3425.322% |
| Nutriband Inc. | 79.82 Thousand USD | -383761.148% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -6733.653% |
| Vor Biopharma Inc. | 31.83 Million USD | -862.68% |
| Roivant Sciences Ltd. | 477.85 Million USD | 35.876% |
| Evogene Ltd. | 10.65 Million USD | -2776.382% |
| ProKidney Corp. | 3.61 Million USD | -8388.116% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -40271.673% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1163848.188% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 82.346% |
| CorMedix Inc. | 517.01 Thousand USD | -59167.562% |
| BioLineRx Ltd. | 6.62 Million USD | -4523.129% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -731.807% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -327.121% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1914.47% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -36275.238% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -120065.098% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -610.13% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -74516.715% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -22282.834% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -46110.445% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -72.079% |
| Biomea Fusion, Inc. | 7.83 Million USD | -3813.423% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -7.814% |
| Mereo BioPharma Group plc | 5.3 Million USD | -5681.528% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -14152.14% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -52012.415% |
| Absci Corporation | 4.66 Million USD | -6475.558% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -2559.443% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -1250.17% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -2962.679% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -2563.372% |
| Allakos Inc. | 38.21 Million USD | -701.834% |
| Imunon, Inc. | 1.13 Million USD | -26795.715% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -3451.06% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -36553.23% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -3064110.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -246.842% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -6407.135% |
| XOMA Corporation | 118.51 Million USD | -158.544% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -2943.212% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -726.4% |
| aTyr Pharma, Inc. | 13.76 Million USD | -2125.765% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -3779.238% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1127.452% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -1416.56% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -2042706.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -110048.1% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2019.848% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 79.562% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -224923.316% |
| UroGen Pharma Ltd. | 98.55 Million USD | -210.926% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -105.494% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -1507.075% |
| Entera Bio Ltd. | 256 Thousand USD | -119595.703% |
| GH Research PLC | 631 Thousand USD | -48461.173% |
| Lisata Therapeutics, Inc. | 137.00 USD | -223664863.504% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -47629.128% |
| Xencor, Inc. | 14.64 Million USD | -1992.754% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -203839.408% |
| Replimune Group, Inc. | 71.99 Million USD | -325.644% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -204180.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -4273.694% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -224923.316% |
| Portage Biotech Inc. | 7000.00 USD | -4377342.857% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -46110.445% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -21343.037% |
| OncoCyte Corporation | 2.2 Million USD | -13802.949% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -457894.171% |
| Purple Biotech Ltd. | 163 Thousand USD | -187888.344% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -11987.613% |
| scPharmaceuticals Inc. | 38.81 Million USD | -689.521% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1113.837% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -419654.795% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -16436.481% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -1062.976% |
| Curis, Inc. | 1.48 Million USD | -20478.979% |
| Daré Bioscience, Inc. | 3.91 Million USD | -7729.493% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -43817.789% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -5106916.667% |
| BeiGene, Ltd. | 197.61 Million USD | -55.057% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -33517.224% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -280.293% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -490.532% |
| bluebird bio, Inc. | 224.41 Million USD | -36.54% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 48.335% |
| DBV Technologies S.A. | 4.52 Million USD | -6670.239% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -22767.239% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -3045.36% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -8034.351% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 18.778% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -614.651% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -17746.302% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -32919.504% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1654.285% |
| MacroGenics, Inc. | 30.19 Million USD | -914.773% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -1630.899% |
| Prime Medicine, Inc. | 4.35 Million USD | -6932.844% |
| Aditxt, Inc. | 1.04 Million USD | -29314.232% |
| Adagene Inc. | 13.54 Million USD | -2163.074% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2130.625% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 40.926% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1692.67% |
| SciSparc Ltd. | 24 Thousand USD | -1276654.167% |
| Vericel Corporation | 81.85 Million USD | -274.342% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -273.607% |
| Generation Bio Co. | 89.77 Million USD | -241.325% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -1281.208% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -51.845% |
| Invivyd, Inc. | 722 Thousand USD | -42340.582% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -531.77% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -10480382.124% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -7911.007% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -1332165.217% |
| 2seventy bio, Inc. | 244.01 Million USD | -25.576% |
| ADMA Biologics, Inc. | 130.59 Million USD | -134.636% |
| Clene Inc. | 7.15 Million USD | -4184.41% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -8975.755% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -23.748% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -27731.153% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -116469.722% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -59.081% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -978.833% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -3078.971% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -174.391% |
| Evaxion Biotech A/S | 8.48 Million USD | -3509.731% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -308.97% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -373.493% |
| Trevena, Inc. | 35.23 Million USD | -769.699% |
| Surrozen, Inc. | 882 Thousand USD | -34641.61% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -4829.553% |
| Cingulate Inc. | 135.09 Thousand USD | -226712.19% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1201.759% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -541.048% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -170133.889% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1107.38% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1657.303% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -32637.286% |
| Statera Biopharma, Inc. | 11.43 Million USD | -2580.581% |
| ImmunityBio, Inc. | 836.95 Million USD | 63.388% |
| Korro Bio, Inc. | 31.21 Million USD | -881.615% |
| Kineta, Inc. | 150 Thousand USD | -204180.667% |
| BioVie Inc. | 349.89 Thousand USD | -87475.38% |
| Codexis, Inc. | 12.24 Million USD | -2402.826% |
| Celularity Inc. | 26.17 Million USD | -1070.573% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -544.351% |
| Celcuity Inc. | 37.03 Million USD | -727.373% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -173662.227% |
| Cibus, Inc. | 17.67 Million USD | -1633.739% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -8968.393% |
| Kodiak Sciences Inc. | 100 Million USD | -206.421% |
| Annexon, Inc. | 29.19 Million USD | -949.746% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -374.138% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -27210.25% |
| Avalo Therapeutics, Inc. | 2 Million USD | -15221.05% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 78.119% |
| Eyenovia, Inc. | 8.95 Million USD | -3320.934% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -366.685% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -3663.461% |
| Arcellx, Inc. | 50.84 Million USD | -502.705% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -20916.529% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -1342.796% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -28944.645% |
| Moolec Science SA | 99.04 Thousand USD | -309272.413% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -1009.377% |
| Geron Corporation | 35.05 Million USD | -774.215% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -51747.885% |
| Royalty Pharma plc | 6.13 Billion USD | 95.006% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -18561.449% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -965248.749% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1223.747% |
| Humacyte, Inc. | 38.6 Million USD | -693.837% |
| Structure Therapeutics Inc. | 4.01 Million USD | -7535.709% |
| 89bio, Inc. | 24.79 Million USD | -1135.818% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -2364.38% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -16321.275% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -29591.957% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -207.936% |
| Notable Labs, Ltd. | 1.52 Million USD | -19980.013% |
| Liquidia Corporation | 2.36 Million USD | -12861.971% |
| Mustang Bio, Inc. | 1.97 Million USD | -15391.456% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2130.625% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -4307.033% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -96562.776% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -514.353% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -3090.556% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -467796.899% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -225209.559% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -4791.778% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -235608.462% |
| PepGen Inc. | 17.1 Million USD | -1691.936% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -64545.781% |
| United Therapeutics Corporation | 300 Million USD | -2.14% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1179.901% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -7260.843% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -52914.014% |
| XOMA Corporation | 118.51 Million USD | -158.544% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -828064.865% |
| Bionomics Limited | 117.62 Million USD | -160.5% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -32742.551% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5362.05% |
| uniQure N.V. | 130.06 Million USD | -135.591% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -422.992% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -44567.784% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -6965.276% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -22024.26% |
| Altimmune, Inc. | 175 Thousand USD | -174997.714% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 20.997% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5362.05% |
| Compugen Ltd. | 719 Thousand USD | -42517.663% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -5948.579% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -262.393% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -2985.811% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -4703.59% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -235.216% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -2985.811% |
| Instil Bio, Inc. | 81.42 Million USD | -276.314% |
| argenx SE | 15.35 Million USD | -1895.708% |
| Immunome, Inc. | 1.34 Million USD | -22767.239% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -57068.097% |
| Verona Pharma plc | 48.37 Million USD | -533.442% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -3224.881% |
| Shattuck Labs, Inc. | 3.4 Million USD | -8896.506% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -360395.294% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -182293.452% |
| Moolec Science SA | 99.04 Thousand USD | -309272.413% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -2677.549% |
| AnaptysBio, Inc. | 16.03 Million USD | -1810.713% |
| Design Therapeutics, Inc. | 2.33 Million USD | -13028.578% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1131816.073% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -5007.017% |
| Achilles Therapeutics plc | 1.07 Million USD | -28377.788% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -3224.881% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1536923.475% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1730.206% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -383761.148% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -4106869.575% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -2356984.615% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 10.529% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1151.515% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -12156.889% |
| Palisade Bio, Inc. | 90 Thousand USD | -340367.778% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -157848.969% |
| Beam Therapeutics Inc. | 159.91 Million USD | -91.62% |
| Neurogene Inc. | 13.37 Million USD | -2191.341% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -1066.74% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -512121.256% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -30542.1% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -656.446% |
| Athira Pharma, Inc. | 1.21 Million USD | -25078.389% |
| Vaccinex, Inc. | 26 Thousand USD | -1178442.308% |
| HCW Biologics Inc. | 6.3 Million USD | -4760.494% |
| XOMA Corporation | 118.51 Million USD | -158.544% |
| Nektar Therapeutics | 112.62 Million USD | -172.072% |
| Arvinas, Inc. | 800 Thousand USD | -38202.625% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2019.848% |
| Merus N.V. | 10.48 Million USD | -2821.634% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -1958.589% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -2181.786% |
| Rezolute, Inc. | 1.66 Million USD | -18359.096% |
| Clene Inc. | 7.15 Million USD | -4184.41% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -417663.266% |
| BeyondSpring Inc. | 3.36 Million USD | -9008.829% |
| Synlogic, Inc. | 12.49 Million USD | -2353.134% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -838.33% |
| Krystal Biotech, Inc. | 6.62 Million USD | -4528.716% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -79.278% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -5010.424% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -646753.56% |
| MannKind Corporation | 252.15 Million USD | -21.523% |
| Ikena Oncology, Inc. | 7.18 Million USD | -4167.702% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -153880.402% |
| Gossamer Bio, Inc. | 197.4 Million USD | -55.225% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -58827.115% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -8.919% |
| Mural Oncology plc | 8.91 Million USD | -3338.683% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -600.615% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -21238.51% |
| Champions Oncology, Inc. | 6.09 Million USD | -4929.066% |
| REGENXBIO Inc. | 82.22 Million USD | -272.675% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -61928.166% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -6810.713% |
| Vaxart, Inc. | 2.62 Million USD | -11582.082% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -112707.816% |
| Cellectis S.A. | 36.24 Million USD | -745.509% |
| Longeveron Inc. | 1.44 Million USD | -21061.671% |
| Repare Therapeutics Inc. | 1.01 Million USD | -30238.713% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 72.943% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -584.449% |
| Revolution Medicines, Inc. | 80.57 Million USD | -280.293% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -9451.777% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -173019.209% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -249022.764% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 57.718% |
| Denali Therapeutics Inc. | 44.98 Million USD | -581.223% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -2350.535% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -226712.19% |
| Passage Bio, Inc. | 22.92 Million USD | -1236.857% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -4974.035% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -47260.278% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -1419.569% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -62434.898% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -75103.273% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -25693.013% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -65655.579% |
| OmniAb, Inc. | 22.07 Million USD | -1288.091% |
| Anew Medical, Inc. | 1.54 Million USD | -19797.468% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -936.607% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -3292.24% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -885.593% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -7458.001% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -494.334% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -4712.643% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2068.738% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -45498.363% |
| Alumis Inc. Common Stock | 30.86 Million USD | -892.939% |
| Equillium, Inc. | 384 Thousand USD | -79697.135% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -4875.175% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -102.862% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -526.897% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -254609.814% |
| Dominari Holdings Inc. | 3.02 Million USD | -10019.584% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1549594.027% |
| vTv Therapeutics Inc. | 169 Thousand USD | -181214.201% |
| Bio-Techne Corporation | 319 Million USD | 3.943% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -437.694% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -71.601% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -1888.843% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -2374.53% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -6274.475% |
| Nkarta, Inc. | 82.27 Million USD | -272.458% |
| BioCardia, Inc. | 982 Thousand USD | -31103.768% |
| Iterum Therapeutics plc | 18.95 Million USD | -1516.486% |